Deals-lir

Subscribe today for access to
Articles and Reports

By Ron Shinkman | Jul 31, 2025 | 1 min read

The $100 million deal will take advantage of LEX VELO technology to detect influenza and SARS-CoV-2

By Ron Shinkman | Jun 30, 2025 | 1 min read

The majority of Labcorp’s revenue growth in the first quarter came from clinical lab acquisitions

By Ron Shinkman | Jun 19, 2025 | 1 min read

Labcorp will acquire oncology-related clinical tests services from BioReference’s parent company, OPKO Health

By Ron Shinkman | Jun 4, 2024 | 1 min read

Most of Invitae's employees will be hired by Labcorp, which expects the deal to add about $275 million in annual revenue

By Ron Shinkman | May 1, 2024 | 1 min read

Recently announced collaboration between Viome and Henry Schein allows dentists to offer sample collection for Viome’s assay to patients

By Ron Shinkman | Mar 28, 2024 | 1 min read

Partnership between Mindera and PBM aims to optimize treatment matches for the disorder, as some drugs cost nearly six figures annually

By Ron Shinkman | Mar 5, 2024 | 1 min read

Both companies have made recent moves to diversify further.

By Ron Shinkman | Jan 30, 2024 | 1 min read

More aggressive use of artificial intelligence may mitigate issues that lead to the uneven impact of the disease on this group.

By Glenn S. Demby | Jan 9, 2024 | 1 min read

An overview of the key 2023 mergers and acquisitions in the diagnostics industry and the trends they reveal.

By Glenn S. Demby | Nov 29, 2023 | 1 min read

While Roche has an early lead, Quest recently made key moves to improve its position in the AD patient-initiated blood testing market.

By Glenn S. Demby | Oct 24, 2023 | 1 min read

As is usual at this time of year, deals in the diagnostics industry were up, both in terms of volume and value.

By Glenn S. Demby | Sep 27, 2023 | 1 min read

Here are what G2 Intelligence considers the three most significant deals announced in the period from late August to early September.

By Glenn S. Demby | Aug 31, 2023 | 1 min read

A strategic partnership with Google enables more accurate whole genome sequencing with machine learning.